Oral Vaccine Market Scope And Analysis

  • Report Code : TIPRE00019316
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Oral Vaccine Market Report - Analysis by 2031

Buy Now

Oral Vaccine Market Report Oral Vaccine Market Size and Share Oral Vaccine Market Scope and Analysis

Oral Vaccine Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 9.4%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Vaccine Type
  • Live vaccine
  • Inactive Vaccine
  • Recombinant Vaccine
By Application
  • Polio
  • Rabies
  • Tuberculosis
  • Influenza
  • Respiratory infections
  • HIV
By End User
  • Hospitals
  • Government vaccination programs
  • Research institutes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Serum Institute of India Pvt Ltd
  • GlaxoSmithKline Plc
  • Merck and Co Inc
  • Aventis
  • PaxVax Corporation
  • VALNEVA Canada Inc
  • Janssen Pharmaceuticals
  • Shanghai BravoBio Co Ltd
  • Swiss Serum and Vaccine Institute Berne
    		•